unlock_ launches the Market Access & Reimbursement program

8 december 2023

Are you planning to raise your next investment round and/or are you creating your market access strategy, but you need to find out how reimbursement works in your target market? Apply now for the unlock_ Market Access & Reimbursement program from January-March or September-December 2023.

With the unlock_ Market Access & Reimbursement (MA&R) program we will support you in increasing your investor readiness level by:

  • Helping you understand the main elements of a MA&R strategy;
  • Help you understand and answer the critical questions that form the basis of your MA&R strategy, irrespective of the market that you are aiming for;
  • Understand how investors will evaluate your technology in terms of opportunities and obstacles to market adoption and market sizing.

Across three training days, you will work on building the skills and answering the most critical questions for your MA&R strategy. During the individual research track, you can choose a market of your choice. Together with experts from Hull Associates, you will map out how your technology fits in the local market and reimbursement system, and what your strategy needs to be in order to enter that market. The costs of this program can be fully covered by the ZorgTech program voucher. Are you interested in the program or want to know more? View the program brochure and additional information 

Share this article

View all latest articles

28 augustus 2026
Axite Data Scientist Discusses the Future of EEG
On Thursday, August 20, Dirk van Moorselaar of PLNT spin-off Axite joined Ron Le...
5 augustus 2026
Bionomic on New Business Radio Live!
On Thursday, July 30, Diederik Mud, CEO and co-founder of PLNT spin-off Bionomic...
5 augustus 2026
Record investments don’t tell the whole story
On Thursday, July 23, our CEO Bastiaan de Roo was a guest on New Business Radio ...
21 juli 2026
GenLumina switches off cancer with light
Current cancer treatments often kill many healthy cells alongside cancer cells. ...
6 juli 2026
80% of quantum chips fail, QuantaMap is committed to changing that
Quantum chips are getting better and better, but no one understands exactly why ...
11 juni 2026
Co-founding the right way with Dr. Jana Nevrlka
On June 11, PLNT welcomed Dr. Jana Nevrlka for a special program day organized b...
28 mei 2026
Akin Solutions is moving to Delft!
After a valuable period within our community, Akin Solutions is taking another s...
21 mei 2026
Gateway Bio wins Audience Award and Rough Diamond Award at the Philips Innovation Awards!
Cool news! Gateway Bio, startup from the unlock_ cohort 2026-2027, won both the ...
12 mei 2026
The new unlock_ cohort has started
As of April, the new unlock_ cohort has begun. Ten Live Sciences & Health st...
16 april 2026
unlock_ cohort 2025-2026 has passed!
Yesterday was the official graduation of the unlock_cohort 2025-2026! The startu...
6 maart 2026
Radigene aims to take cell and gene therapy out of the ‘black box’
Cell and gene therapies offer enormous opportunities for patients with serious d...
2 maart 2026
Gulliver Startup Awards 2026
On Friday, February 27, the festive finals of the Gulliver Startup Awards took p...